Status:
UNKNOWN
Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study
Lead Sponsor:
University Hospital Southampton NHS Foundation Trust
Collaborating Sponsors:
University of Southampton
Conditions:
Covid19
SARS-CoV-2 Infection
Eligibility:
All Genders
Brief Summary
This project aims to undertake a high-resolution analysis of previous cases of COVID19 infection to determine from all available clinical data recorded over the timeline of admission, who might benefi...
Detailed Description
Purpose: The primary purpose of this research is to identify an early warning for hyperinflammation in COVID19 so that interventional trials of anti-inflammatory agents can target this sub-group. Ba...
Eligibility Criteria
Inclusion
- Sars-CoV-2 confirmed
- Hospitalized case
Exclusion
- Sars-CoV-2 not confirmed
Key Trial Info
Start Date :
June 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 24 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04903834
Start Date
June 30 2020
End Date
June 24 2024
Last Update
May 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Southampton NHS Foundation Trust
Southampton, Hampshire, United Kingdom, SO16 6YD